Abstract
In view of the problems associated with the use of conventional foot and mouth disease (FMD) vaccines, such as antigenic variability of the FMD virus, the cost of vaccination programmes and problems associated with vaccine storage, alternative approaches to the design of FMD virus are discussed. Identification of the antigenic site of the FMD virus and isolation or synthesis of the peptides which make up the antigenic site are considered for vaccine use.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
